Bio Green Med Solution, Inc.(BGMS)Earnings, Financials & Key Ratios
BGMS•NASDAQ
$1.00
$22314 mkt cap·Price updated May 6, 2026
AboutA diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportunities in biopharmaceutical research and fire safety solutions to create sustainable long-term shareholder value.Show more
- Revenue$43K-89.8%
- EBITDA-$12M+52.8%
- Net Income-$11M+50.3%
- EPS (Diluted)-501.60+92.2%
- Gross Margin100%
- EBITDA Margin-27902.33%-361.0%
- Operating Margin-27916.28%-360.6%
- Net Margin-26074.42%-385.5%
BGMS Key Insights
Bio Green Med Solution, Inc. (BGMS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 1/9
- ✗Negative free cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
BGMS Price & Volume
Bio Green Med Solution, Inc. (BGMS) stock price & volume — 10-year historical chart
Loading chart...
BGMS Growth Metrics
Bio Green Med Solution, Inc. (BGMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-30.91%
5 Years-
3 Years-
TTM9.46%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM59.5%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM96.97%
Return on Capital
10 Years-86.48%
5 Years-110.62%
3 Years-167.63%
Last Year-
BGMS Peer Comparison
Bio Green Med Solution, Inc. (BGMS) competitors in Diversified Holdings and Investment Companies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GRWG | 81.98M | 1.37 | -3.43 | -14.36% | -14.87% | -22.9% | 0.30 | |
 SMG | 3.65B | 62.85 | 25.45 | -3.93% | 2.68% | |||
 IIPR | 1.65B | 57.69 | 14.68 | -13.8% | 45.58% | 6.41% | 0.21 | |
 LWAY | 405.93M | 26.65 | 29.94 | 13.74% | 6.52% | 17.25% | 0.00 | |
 HYFM | 5.32M | 1.14 | -0.08 | -16.02% | -44.49% | -32.29% | 0.76 | |
 BYFC | 86.03M | 9.25 | -2.86 | -3.76% | -9.05% | 0.58 | ||
 XXII | 621.21K | 0.85 | -63.12% | -65.69% | -79.16% | 2.15 |
Compare BGMS vs Peers
Bio Green Med Solution, Inc. (BGMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BGMS Income Statement
Bio Green Med Solution, Inc. (BGMS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 843K | 0 | 150K | 0 | 0 | 0 | 0 | 420K | 43K | 81K |
| Revenue Growth % | -56.64% | -100% | - | -100% | - | - | - | - | -89.76% | 9.46% |
| Cost of Goods Sold | 9.48M | 4.24M | 4.33M | 4.66M | 20K | 43K | 32K | 0 | 0 | 66K |
| COGS % of Revenue | 1124.2% | - | 2884.67% | - | - | - | - | - | - | - |
| Gross Profit | -8.63M▲ 0% | -4.24M▲ 50.9% | -4.18M▲ 1.4% | -4.66M▼ 11.5% | -20K▲ 99.6% | -43K▼ 115.0% | -32K▲ 25.6% | 420K▲ 1412.5% | 43K▼ 89.8% | 15K▲ 0% |
| Gross Margin % | -1024.2% | - | -2784.67% | - | - | - | - | 100% | 100% | 18.52% |
| Gross Profit Growth % | 17.28% | 50.93% | 1.42% | -11.52% | 99.57% | -115% | 25.58% | 1412.5% | -89.76% | - |
| Operating Expenses | 5.52M | 5.25M | 5.37M | 5.02M | 10.62M | 22.39M | 27.66M | 25.87M | 12.05M | 9.19M |
| OpEx % of Revenue | 654.33% | - | 3580.67% | - | - | - | - | 6160.24% | 28016.28% | - |
| Selling, General & Admin | 5.52M | 5.25M | 5.37M | 5.02M | 5.88M | 7.46M | 7.38M | 6.72M | 5.39M | 7.42M |
| SG&A % of Revenue | 654.33% | - | 3580.67% | - | - | - | - | 1599.52% | 12539.53% | - |
| Research & Development | 9.48M | 4.24M | 4.33M | 4.66M | 4.74M | 14.93M | 20.27M | 19.16M | 6.66M | 1.77M |
| R&D % of Revenue | 1124.2% | - | 2884.67% | - | - | - | - | 4560.71% | 15476.74% | - |
| Other Operating Expenses | -9.48M | -4.24M | -4.33M | -4.66M | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.15M▲ 0% | -9.49M▲ 32.9% | -9.55M▼ 0.6% | -9.68M▼ 1.4% | -10.64M▼ 9.9% | -22.39M▼ 110.5% | -27.66M▼ 23.5% | -25.45M▲ 8.0% | -12M▲ 52.8% | -9.17M▲ 0% |
| Operating Margin % | -1678.53% | - | -6365.33% | - | - | - | - | -6060.24% | -27916.28% | -11324.69% |
| Operating Income Growth % | 12.49% | 32.93% | -0.6% | -1.4% | -9.85% | -110.5% | -23.52% | 7.97% | 52.84% | - |
| EBITDA | -14.02M | -9.46M | -9.52M | -9.66M | -10.62M | -22.35M | -27.62M | -25.42M | -12M | -9.17M |
| EBITDA Margin % | -1662.75% | - | -6346% | - | - | - | - | -6052.86% | -27902.33% | -11318.52% |
| EBITDA Growth % | 12.17% | 32.52% | -0.63% | -1.5% | -9.87% | -110.49% | -23.62% | 7.97% | 52.8% | 51.36% |
| D&A (Non-Cash Add-back) | 133K | 32K | 29K | 20K | 20K | 43K | 32K | 31K | 6K | 5K |
| EBIT | -14.15M | -9.49M | -9.55M | -9.68M | -9.68M | -22.39M | -27.66M | -25.45M | -12M | -9.23M |
| Net Interest Income | 37K | 118K | 331K | 224K | 42K | 16K | 210K | 266K | 12K | 47K |
| Interest Income | 37K | 118K | 331K | 224K | 42K | 16K | 210K | 266K | 12K | 47K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 376K | 1.03M | 923K | 556K | 955K | 204K | 1.74M | -98K | 10K | 4.93M |
| Pretax Income | -13.77M▲ 0% | -8.46M▲ 38.6% | -8.63M▼ 1.9% | -9.13M▼ 5.8% | -9.68M▼ 6.1% | -22.18M▼ 129.2% | -25.91M▼ 16.8% | -25.55M▲ 1.4% | -11.99M▲ 53.1% | -4.24M▲ 0% |
| Pretax Margin % | -1633.93% | - | -5750% | - | - | - | - | -6083.57% | -27893.02% | -5238.27% |
| Income Tax | 1.98M | 993K | 1.34M | 1.3M | -1.24M | -3.73M | -4.72M | -3M | -782K | 1.2M |
| Effective Tax Rate % | -14.4% | -11.73% | -15.5% | -14.2% | 12.77% | 16.8% | 18.2% | 11.73% | 6.52% | -28.19% |
| Net Income | -11.79M▲ 0% | -7.47M▲ 36.6% | -7.29M▲ 2.4% | -7.83M▼ 7.4% | -8.45M▼ 7.9% | -18.46M▼ 118.6% | -21.2M▼ 14.9% | -22.55M▼ 6.4% | -11.21M▲ 50.3% | -5.44M▲ 0% |
| Net Margin % | -1398.7% | - | -4858.67% | - | - | - | - | -5370.24% | -26074.42% | -6714.81% |
| Net Income Growth % | 17.79% | 36.65% | 2.44% | -7.44% | -7.85% | -118.56% | -14.85% | -6.4% | 50.29% | 59.5% |
| Net Income (Continuing) | -11.79M | -7.47M | -7.29M | -7.83M | -8.45M | -18.46M | -21.2M | -22.55M | -11.21M | -5.44M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -252000.00▲ 0% | -140400.00▲ 44.3% | -44584.00▲ 68.2% | -35426.00▲ 20.5% | -12306.00▲ 65.3% | -7704.00▲ 37.4% | -6840.00▲ 11.2% | -6420.00▲ 6.1% | -501.60▲ 92.2% | -2.84▲ 0% |
| EPS Growth % | 35.19% | 44.29% | 68.25% | 20.54% | 65.26% | 37.4% | 11.21% | 6.14% | 92.19% | 96.97% |
| EPS (Basic) | -252000.00 | -140400.00 | -44584.00 | -35426.00 | -12306.00 | -7704.00 | -6840.00 | -6420.00 | -501.60 | - |
| Diluted Shares Outstanding | 48 | 106 | 168 | 227 | 1.01K | 2.48K | 3.13K | 3.54K | 22.31K | 1.91M |
| Basic Shares Outstanding | 48 | 106 | 168 | 227 | 1.01K | 2.48K | 3.13K | 3.54K | 22.31K | 754.91K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
BGMS Balance Sheet
Bio Green Med Solution, Inc. (BGMS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 19.62M | 25.97M | 19.79M | 14.02M | 35.47M | 40.94M | 24.41M | 7.44M | 3.67M | 6.44M |
| Cash & Short-Term Investments | 16.65M | 24.04M | 17.5M | 11.88M | 33.41M | 36.56M | 18.34M | 3.38M | 3.14M | 3.84M |
| Cash Only | 16.52M | 23.91M | 17.5M | 11.88M | 33.41M | 36.56M | 18.34M | 3.38M | 3.14M | 3.84M |
| Short-Term Investments | 132K | 132K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.06M | 1.49M | 1.5M | 1.33M | 1.31M | 4.3M | 5.64M | 3.73M | 237K | 725K |
| Days Sales Outstanding | 890.63 | - | 3.66K | - | - | - | - | 3.24K | 2.01K | 1.14K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.37M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 1.89K |
| Other Current Assets | 41K | 81K | -120K | 103K | 66K | -498K | 426K | 341K | 300K | 460K |
| Total Non-Current Assets | 45K | 29K | 36K | 1.29M | 1.33M | 2.19M | 3.64M | 1.36M | 419K | 1.71M |
| Property, Plant & Equipment | 45K | 29K | 36K | 1.29M | 1.33M | 94K | 174K | 102K | 7K | 144K |
| Fixed Asset Turnover | 18.73x | - | 4.17x | - | - | - | - | 4.12x | 6.14x | 1.71x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.57M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 2.1M | 3.46M | 1.26M | 412K | 412K |
| Total Assets | 19.66M▲ 0% | 26M▲ 32.3% | 19.82M▼ 23.8% | 15.31M▼ 22.8% | 36.8M▲ 140.4% | 43.14M▲ 17.2% | 28.05M▼ 35.0% | 8.8M▼ 68.6% | 4.09M▼ 53.5% | 8.16M▲ 0% |
| Asset Turnover | 0.04x | - | 0.01x | - | - | - | - | 0.05x | 0.01x | 0.02x |
| Asset Growth % | -20.6% | 32.25% | -23.77% | -22.78% | 140.41% | 17.21% | -34.97% | -68.61% | -53.5% | -87.59% |
| Total Current Liabilities | 5.26M | 4.11M | 4.45M | 2.42M | 2.49M | 5.41M | 7.51M | 8.16M | 6.27M | 1M |
| Accounts Payable | 2.5M | 1.56M | 2.72M | 890K | 514K | 2.12M | 2.56M | 3.54M | 4.6M | 468K |
| Days Payables Outstanding | 96.17 | 134.22 | 229.36 | 69.74 | 9.38K | 17.97K | 29.21K | - | - | 7.47K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 430K | 662K | 363K | 678K | 866K | 753K | 1.01M | 380K | 283K | 534K |
| Current Ratio | 3.73x | 6.32x | 4.45x | 5.79x | 14.27x | 7.56x | 3.25x | 0.91x | 0.59x | 0.59x |
| Quick Ratio | 3.73x | 6.32x | 4.45x | 5.79x | 14.27x | 7.56x | 3.25x | 0.91x | 0.59x | 0.59x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -4.44K |
| Total Non-Current Liabilities | 130K | 124K | 100K | 1.19M | 1.06M | 30K | 106K | 37K | 0 | 60K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.19M | 1.06M | 30K | 106K | 37K | 0 | 24K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 130K | 124K | 100K | 0 | 0 | 0 | 0 | 0 | 0 | 55K |
| Total Liabilities | 5.39M | 4.24M | 4.55M | 3.61M | 3.54M | 5.44M | 7.62M | 8.2M | 6.27M | 1.06M |
| Total Debt | 0 | 0 | 0 | 1.19M | 1.06M | 30K | 106K | 37K | 0 | 5K |
| Net Debt | -16.52M | -23.91M | -17.5M | -10.69M | -32.35M | -36.53M | -18.24M | -3.34M | -3.14M | -3.83M |
| Debt / Equity | - | - | - | 0.10x | 0.03x | 0.00x | 0.01x | 0.06x | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.00x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.42x |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 14.27M▲ 0% | 21.77M▲ 52.5% | 15.27M▼ 29.8% | 11.7M▼ 23.4% | 33.26M▲ 184.3% | 37.69M▲ 13.3% | 20.43M▼ 45.8% | 607K▼ 97.0% | -2.17M▼ 458.2% | 7.1M▲ 0% |
| Equity Growth % | -24.22% | 52.5% | -29.84% | -23.41% | 184.34% | 13.33% | -45.79% | -97.03% | -458.15% | 875.66% |
| Book Value per Share | 300047.65 | 205362.44 | 90918.81 | 51598.89 | 32962.34 | 15204.92 | 6536.47 | 171.23 | -97.43 | 3.71 |
| Total Shareholders' Equity | 14.27M | 21.77M | 15.27M | 11.7M | 33.26M | 37.69M | 20.43M | 607K | -2.17M | 7.1M |
| Common Stock | 4K | 12K | 12K | 1K | 6K | 10K | 4.5M | 1K | 9K | 3K |
| Retained Earnings | -335.04M | -342.51M | -349.8M | -357.63M | -366.07M | -384.53M | -405.73M | -428.28M | -439.49M | -444.26M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -743K | -794K | -760K | -819K | -746K | -748K | -1.32M | -908K | -891K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BGMS Cash Flow Statement
Bio Green Med Solution, Inc. (BGMS) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -10.08M | -7.48M | -6.7M | -9.45M | -7.93M | -18.54M | -20.83M | -16.11M | -7.99M | -7.99M |
| Operating CF Margin % | -1195.61% | - | -4467.33% | - | - | - | - | -3836.19% | -18581.4% | - |
| Operating CF Growth % | 30.3% | 25.79% | 10.41% | -40.98% | 16.02% | -133.68% | -12.34% | 22.64% | 50.41% | -355.33% |
| Net Income | -11.79M | -7.47M | -7.29M | -7.83M | -8.45M | -18.46M | -21.2M | -22.55M | -11.21M | -5.44M |
| Depreciation & Amortization | 133K | 32K | 29K | 20K | 20K | 43K | 32K | 31K | 6K | 2K |
| Stock-Based Compensation | 782K | 266K | 331K | 466K | 430K | 1.16M | 1.51M | 1.47M | 592K | 1.77M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 358K | -1.54M | 554K | -2.32M | -63K | 0 | 0 | 0 | 0 | 4.98M |
| Working Capital Changes | 439K | 1.23M | -327K | 214K | 124K | -1.28M | -1.17M | 4.94M | 2.62M | -7.41M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 3.02M | 2.58M | 296K | -1.81M | -8.48M |
| Cash from Investing | 9K | -13K | -39K | 28K | -96K | -27K | -7K | -6K | 0 | 0 |
| Capital Expenditures | -3K | -13K | -39K | -10K | -96K | -27K | -7K | -6K | 0 | 0 |
| CapEx % of Revenue | 0.36% | - | 26% | - | - | - | - | 1.43% | - | - |
| Acquisitions | 12K | 0 | 0 | 38K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.59M | 14.75M | 429K | 3.85M | 29.5M | 21.74M | 3M | 848K | 7.82M | 7.14M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 6.79M | 14.95M | 630K | 4.05M | 29.7M | 17.37M | 3.2M | 1.05M | 6.21M | 7.18M |
| Dividends Paid | -200K | -201K | -201K | -201K | -201K | -201K | -201K | -201K | 0 | -41K |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 4.57M | 0 | 0 | 1.61M | 0 |
| Net Change in Cash | -3.92M▲ 0% | 7.39M▲ 288.5% | -6.41M▼ 186.7% | -5.62M▲ 12.3% | 21.52M▲ 483.0% | 3.15M▼ 85.3% | -18.21M▼ 677.7% | -14.97M▲ 17.8% | -241K▲ 98.4% | 856K▲ 0% |
| Free Cash Flow | -10.08M▲ 0% | -7.49M▲ 25.7% | -6.74M▲ 10.0% | -9.46M▼ 40.3% | -8.03M▲ 15.1% | -18.57M▼ 131.2% | -20.83M▼ 12.2% | -16.12M▲ 22.6% | -7.99M▲ 50.4% | -6.09M▲ 0% |
| FCF Margin % | -1195.97% | - | -4493.33% | - | - | - | - | -3837.62% | -18581.4% | -7522.22% |
| FCF Growth % | 30.44% | 25.68% | 10.05% | -40.31% | 15.09% | -131.22% | -12.21% | 22.64% | 50.43% | 42.21% |
| FCF per Share | -211944.26 | -70696.53 | -40125.24 | -41717.59 | -7958.37 | -7489.71 | -6664.75 | -4546.69 | -358.07 | -358.07 |
| FCF Conversion (FCF/Net Income) | 0.85x | 1.00x | 0.92x | 1.21x | 0.94x | 1.00x | 0.98x | 0.71x | 0.71x | 1.12x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 2K | 2K | 0 |
BGMS Key Ratios
Bio Green Med Solution, Inc. (BGMS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -71.23% | -41.46% | -39.35% | -58.07% | -37.57% | -52.03% | -72.94% | -214.4% | - | -187.31% |
| Return on Invested Capital (ROIC) | - | - | - | -723.98% | -833.98% | -1619.26% | -1235.38% | - | - | 899.02% |
| Gross Margin | -1024.2% | - | -2784.67% | - | - | - | - | 100% | 100% | 18.52% |
| Net Margin | -1398.7% | - | -4858.67% | - | - | - | - | -5370.24% | -26074.42% | -6714.81% |
| Debt / Equity | - | - | - | 0.10x | 0.03x | 0.00x | 0.01x | 0.06x | - | 0.00x |
| FCF Conversion | 0.85x | 1.00x | 0.92x | 1.21x | 0.94x | 1.00x | 0.98x | 0.71x | 0.71x | 1.12x |
| Revenue Growth | -56.64% | -100% | - | -100% | - | - | - | - | -89.76% | 9.46% |
BGMS Frequently Asked Questions
Bio Green Med Solution, Inc. (BGMS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Bio Green Med Solution, Inc. (BGMS) reported $0.1M in revenue for fiscal year 2024. This represents a 77% decrease from $0.4M in 2005.
Bio Green Med Solution, Inc. (BGMS) saw revenue decline by 89.8% over the past year.
Bio Green Med Solution, Inc. (BGMS) reported a net loss of $5.4M for fiscal year 2024.
Dividend & Returns
Bio Green Med Solution, Inc. (BGMS) had negative free cash flow of $6.1M in fiscal year 2024, likely due to heavy capital investments.
Explore More BGMS
Bio Green Med Solution, Inc. (BGMS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates